(19)
(11) EP 0 696 285 A1

(12)

(43) Date of publication:
14.02.1996 Bulletin 1996/07

(21) Application number: 94915931.0

(22) Date of filing: 28.04.1994
(51) International Patent Classification (IPC): 
A61K( . )
A61K 31/ 47( . )
C07D 317/ 66( . )
C07D 491/ 22( . )
C07D( . )
A61P 35/ 00( . )
C07D 319/ 18( . )
(86) International application number:
PCT/US1994/004681
(87) International publication number:
WO 1994/025466 (10.11.1994 Gazette 1994/25)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
SI

(30) Priority: 29.04.1993 US 19930054585
22.06.1993 US 19930081042

(71) Applicant: GLAXO WELLCOME INC.
Research Triangle Park, North Carolina 27709 (US)

(72) Inventors:
  • BESTERMAN, Jeffrey, Mark
    Durham, NC 27713 (US)
  • EVANS, Michael, Glenn
    Pittsboro, NC 27312 (US)
  • LUZZIO, Michael, Joseph
    Durham, NC 27707 (US)
  • MYERS, Peter, Leslie
    Chapel Hill, NC 27514 (US)

(74) Representative: Gallafent, Alison, et al 
Glaxo Wellcome plc Glaxo House Berkeley Avenue
Greenford, Middlesex UB6 0NN
Greenford, Middlesex UB6 0NN (GB)

   


(54) WATER SOLUBLE DERIVATIVES OF CAMPTOTHECIN AND THEIR USE AS ANTITUMOR AGENTS